Anticarcinogenic Effects of Isothiocyanates on Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, accounting for about 90% of cases. Sorafenib, lenvatinib, and the combination of atezolizumab and bevacizumab are considered first-line treatments for advanced HCC. However, clinical application of these drugs has also c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuting, Huang, Huiting, Jin, Libo, Lin, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693344/
https://www.ncbi.nlm.nih.gov/pubmed/36430307
http://dx.doi.org/10.3390/ijms232213834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693344/
https://www.ncbi.nlm.nih.gov/pubmed/36430307
http://dx.doi.org/10.3390/ijms232213834

Ejemplares similares